Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

Three years after discussing how to reuse an old scientific measuring device, Novartis scientists are now testing this idea as part of an innovative research project.

Compounds block a protein involved in many cancers by cementing it shut.

A diminutive protein prompts a closer look at DNA dark matter.

The fast-spreading virus can take multiple routes into developing human nerve cells.

Experts call for significant changes to facilitate the discovery of new treatments.

New NIBR President Jay Bradner shares on drug discovery, his leadership style and what’s next for his career in biomedical research.

A cellular computing error wreaks havoc on vision.

Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model